Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choice
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
More News
Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus
Zacks highlights PDF Solutions, LifeStance Health and Paychex among stocks and portfolios that outperformed as markets weighed softer jobs data and earnings.
Zacks
Ensign Expands Texas Footprint With Two Skilled Nursing Acquisitions
ENSG expands its Texas footprint with two skilled nursing acquisitions, adding 250 licensed beds and strengthening its owned real estate portfolio.
Zacks
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Zacks
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
Zacks
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
Zacks
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Zacks
ENSG Expands Healthcare Footprint With Iowa, California Acquisitions
With new acquisitions in California and Iowa, Ensign Group has grown its portfolio to 396 healthcare operations and 181 owned real estate properties.
Zacks
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.